Table 3.
Human leukocyte antigen-DRB1* and human leukocyte antigen-DQB1* alleles in donors and recipients, association with recurrent primary sclerosing cholangitis n (%)
| Donor | rPSC | P value | Recipient | rPSC | P value | |
| HLA-DRB1* | ||||||
| 1 | 5 | 2 (40.0) | 1.000 | 9 | 3 (33.3) | 0.711 |
| 3 | 7 | 2 (28.6) | 0.427 | 23 | 11 (47.8) | 0.767 |
| 4 | 9 | 4 (44.4) | 1.000 | 6 | 0 (0) | 0.029 |
| 5 | 1 | 1 (100) | 0.450 | |||
| 6 | 2 | 2 (100) | 0.196 | |||
| 7 | 15 | 10 (66.7) | 0.050 | 2 | 0 (0) | 0.498 |
| 8 | 2 | 1 (50.0) | 1.000 | |||
| 9 | 1 | 0 (0) | 1.000 | 1 | 1 (100) | 0.435 |
| 10 | 1 | 1 (100) | 0.435 | |||
| 11 | 10 | 4 (40.0) | 1.000 | 5 | 1 (20.0) | 0.369 |
| 12 | 2 | 2 (100) | 0.196 | 1 | 1 (100) | 0.435 |
| 13 | 8 | 2 (25.0) | 0.258 | 10 | 5 (50.0) | 0.726 |
| 14 | 4 | 0 (0) | 0.114 | 1 | 1 (100) | 0.435 |
| 15 | 8 | 3 (37.5) | 0.709 | 15 | 5 (33.3) | 0.365 |
| 16 | 1 | 1 (100) | 0.450 | 3 | 2 (66.7) | 0.572 |
| HLA-DQB1* | ||||||
| 2 | 17 | 9 (53.0) | 0.740 | 25 | 10 (40.0) | 1.000 |
| 3 | 20 | 8 (40.0) | 0.740 | 11 | 1 (9.1) | 0.030 |
| 7 | 15 | 6 (40.0) | 0.500 | 7 | 0 (0) | 0.031 |
| 8 | 7 | 5 (71.4) | 0.229 | 4 | 0 (0) | 0.140 |
| 9 | 2 | 1 (50.0) | 1.000 | 1 | 1 (100) | 0.395 |
| 4 | 2 | 1 (50.0) | 1.000 | |||
| 5 | 9 | 4 (44.4) | 1.000 | 10 | 5 (50.0) | 0.481 |
| 6 | 13 | 4 (30.8) | 0.164 | 21 | 9 (42.9) | 0.760 |
rPSC: Recurrent primary sclerosing cholangitis.